Pooled allogeneic faecal microbiota MaaT013 for steroid-resistant gastrointestinal acute graft-versus-host disease: a single-arm, multicentre phase 2 trial
-
Published:2023-08
Issue:
Volume:62
Page:102111
-
ISSN:2589-5370
-
Container-title:eClinicalMedicine
-
language:en
-
Short-container-title:eClinicalMedicine
Author:
Malard FlorentORCID, Loschi MichaelORCID, Huynh Anne, Cluzeau Thomas, Guenounou Sarah, Legrand Faezeh, Magro Leonardo, Orvain Corentin, Charbonnier Amandine, Panz-Klapuch Marta, Desmier Deborah, Mear Jean-Baptiste, Cornillon Jérôme, Robin Christine, Daguindau Etienne, Bilger Karin, Vehreschild Maria J.G.T., Chevallier Patrice, Labussière-Wallet Hélène, Mediavilla Clémence, Couturier Marie-Anne, Bulabois Claude-Eric, Camus Vincent, Chantepie Sylvain, Ceballos Patrice, Gaugler Béatrice, Holler Ernst, Doré Joël, Prestat Emmanuel, Gasc Cyrielle, Plantamura Emilie, Mohty Mohamad
Reference32 articles.
1. Mortality, length of stay and costs associated with acute graft-versus-host disease during hospitalization for allogeneic hematopoietic stem cell transplantation;Yu;Curr Med Res Opin,2019 2. Severity of acute graft-versus-host disease and associated healthcare resource utilization, cost, and outcomes;Farhadfar;Transplant Cell Ther,2021 3. First- and second-line systemic treatment of acute graft-versus-host disease: recommendations of the American Society of Blood and Marrow Transplantation;Martin;Biol Blood Marrow Transplant,2012 4. Early treatment of acute graft-versus-host disease with high- or low-dose 6-methylprednisolone: a multicenter randomized trial from the Italian Group for Bone Marrow Transplantation;Van Lint;Blood,1998 5. Etanercept, mycophenolate, denileukin, or pentostatin plus corticosteroids for acute graft-versus-host disease: a randomized phase 2 trial from the Blood and Marrow Transplant Clinical Trials Network;Alousi;Blood,2009
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
|
|